Radiosynthesis of a new PSMA targeting ligand ([18F]FPy-DUPA-Pep)

Applied Radiation and Isotopes

Volumn 69, Issue 7, 2011, Pages 1014-1018

  Malik, Noeen ^a   Machulla, Hans Jürgen ^a   Solbach, Christoph ^a   Winter, Gordon ^a   Reske, Sven N ^a   Zlatopolskiy, Boris ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

18F FPy DUPA Pep; PSMA targeting ligand; Radiosynthesis

Indexed keywords

[18F]FPY-DUPA-PEP; CHEMICAL PURITY; PHENYLALANINE RESIDUES; PROSTATE CANCER CELLS; PROSTATE-SPECIFIC MEMBRANE ANTIGENS; PROSTHETIC GROUPS; PSMA TARGETING LIGAND; RADIOCHEMICAL YIELD; RADIOSYNTHESIS;

AMINO ACIDS; DISEASES; ESTERS; LIGANDS; MONOPOLE ANTENNAS;

FLUORINE;

FLUORONICOTINIC ACID 2 [3 (1,3 DICARBOXYPROPYL)UREIDO]PENTANEDIOIC ACID 8 AMINOOCTANOIC ACID PHENYLALANYLPHENYLALANINEAMIDE F 18; TRACER; UNCLASSIFIED DRUG;

ARTICLE; DRUG PURITY; DRUG SYNTHESIS; PRIORITY JOURNAL; RADIOCHEMISTRY;

ANTIGENS, SURFACE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORINE RADIOISOTOPES; GLUTAMATE CARBOXYPEPTIDASE II; LIGANDS; RADIOPHARMACEUTICALS;

EID: 79955580444     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2011.03.041     Document Type: Article

References (17)

1. ACD/LogP Freeware. 〈〉. http://www.acdlabs.com/resources/freeware/chemsketch/logp/.
2. Becaud J., Mu L., Karramkam M., Schubiger P.A., Ametamey S.M., Graham K., Stellfeld T., Lehmann L., Borkowski S., Berndorff D., Dinkelborg L., Srinivasan A., Smits R., Koksch B. Direct one-step 18F-labeling of peptides via nucleophilic aromatic substitution. Bioconjugate Chem. 2009, 20(12):2254-2261.
3. Elsässer-B U., Reischl G., Wiehr S., Bühler P., Wolf P., Alt K., Shively J., Judenhofer M.S., Machulla H.-J., Pichler B.J. PET imaging of prostate cancer xenografts prostate-specific membrane antigen. J. Nucl. Med. 2009, 50(4):606-611.
4. Ghosh A., Heston W.D.W. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J. Cell Biochem. 2004, 91(3):528-539.
5. Glaser M., Årstad E., Luthra S.K., Robins E.G. Two-step radiosynthesis of [18F]-N-succinimidyl-4-fluorobenzoate ([18F]SFB). J. Labelled Compd. Radiopharm. 2009, 52(8):327-330.
6. Goodman O.B., Barwe S.P., Ritter B., McPherson P.S., Vasko A.-J., Keen J.H., Nanus D.M., Bander N.H., Rajasekaran A.K. Interaction of prostate specific membrane antigen with a highly specific antibody against the clathrin and the adaptor protein complex-2. Int. J. Oncol. 2007, 31(5):1199-1203.
7. Kim D.W., Jeong H.-J., Lim S.T., Sohn M.-H., Katzenellenbogen J.A., Chi D.Y. Facile nucleophilic fluorination reactions using tert-alcohols as a reaction medium: significantly enhanced reactivity of alkali metal fluorides and improved selectivity. J. Org. Chem. 2008, 73:957-962.
8. Kularatne S.A., Zhou Z., Yang J., Post C.B., Low P.S. Design, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted 99mTc-radioimaging agents. Mol. Pharm. 2009, 6(3):790-800.
9. Kularatne S.A., Wang K., Santhapuram H.-K.R., Low P.S. Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand. Mol. Pharm. 2009, 6(3):780-789.
10. Kularatne S.A., Venkatesh C., Santhapuram H.-K.R., Wang K., Vaitilingam B., Henne W.A., Low P.S. Synthesis and biological analysis of prostate-specific membrane antigen-targeted anticancer prodrugs. J. Med. Chem. 2010, 53(21):7767-7777.
11. Laverman P., McBride W.J., Sharkey R.M., Eek A., Joosten L., Oyen W.J., Goldenberg D.M., Boerman O.C. A novel facile method of labeling octreotide with 18F-fluorine. J. Nucl. Med. 2010, 51(3):454-461.
12. Ma Dangshe, Hopf C.E., Malewicz A.D., Donovan G.P., Senter P.D., Goeckeler W.F., Maddon P.J., Olson W.C. Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen. Clin. Cancer Res. 2006, 12(8):2591-2596.
13. Olberg D.E., Arukwe J.M., Grace D., Hjelstuen O.K., Solbakken M., Kindberg G.M., Cuthbertson A. One step radiosynthesis of 6-[18F]fluoronicotinic acid 2,3,5,6-tetrafluorophenyl ester ([18F]F-Py-TFP): a new prosthetic group for efficient labeling of biomolecules with fluorine-18. J. Med. Chem. 2010, 53(4):1732-1740.
14. Olson W.C., Heston W.D.W., Rajasekaran A.K. Clinical trials of cancer therapies targeting prostate-specific membrane antigen. Rev. Recent Clin. Trials 2007, 2:182-190.
15. Scott P.J.H., Shao X. Fully automated, high yielding production of N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB), and its use in microwave-enhanced radiochemical coupling reactions. J. Labelled Compd. Radiopharm. 2010, 53(9):586-591.
16. Silver D.A., Pellicer I., Fair W.R., Heston W.D.W., Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin. Cancer Res. 1997, 3(1):81-85.
17. Tang G., Zeng W., Yu M., Kabalka G. Facile synthesis of N-succinimidyl 4-[18F]fluorobenzoate [18F]SFB for protein labeling. J. Labelled Compd. Radiopharm. 2008, 51(1):68-71.